These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 36113527)

  • 1. Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling study.
    Winter AK; Lambert B; Klein D; Klepac P; Papadopoulos T; Truelove S; Burgess C; Santos H; Knapp JK; Reef SE; Kayembe LK; Shendale S; Kretsinger K; Lessler J; Vynnycky E; McCarthy K; Ferrari M; Jit M
    Lancet Glob Health; 2022 Oct; 10(10):e1412-e1422. PubMed ID: 36113527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study.
    Auzenbergs M; Fu H; Abbas K; Procter SR; Cutts FT; Jit M
    Lancet Glob Health; 2023 Aug; 11(8):e1194-e1204. PubMed ID: 37474227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: a modelling study.
    Hartner AM; Li X; Echeverria-Londono S; Roth J; Abbas K; Auzenbergs M; de Villiers MJ; Ferrari MJ; Fraser K; Fu H; Hallett T; Hinsley W; Jit M; Karachaliou A; Moore SM; Nayagam S; Papadopoulos T; Perkins TA; Portnoy A; Minh QT; Vynnycky E; Winter AK; Burrows H; Chen C; Clapham HE; Deshpande A; Hauryski S; Huber J; Jean K; Kim C; Kim JH; Koh J; Lopman BA; Pitzer VE; Tam Y; Lambach P; Sim SY; Woodruff K; Ferguson NM; Trotter CL; Gaythorpe KAM
    Lancet Glob Health; 2024 Apr; 12(4):e563-e571. PubMed ID: 38485425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey.
    Kriss JL; Grant GB; Moss WJ; Durrheim DN; Shefer A; Rota PA; Omer SB; Masresha BG; Mulders MN; Hanson M; Linkins RW; Goodson JL
    Vaccine; 2019 Sep; 37(38):5745-5753. PubMed ID: 30898393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries.
    Levin A; Burgess C; Shendale S; Morgan W; Cw Hutubessy R; ; Jit M;
    BMJ Glob Health; 2023 Jul; 8(7):. PubMed ID: 37429697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The State of Measles and Rubella in the WHO European region.
    Muscat M; Ben Mamou M; Shefer A; Jankovic D; Deshevoy S; Butler R
    Rev Esp Salud Publica; 2015; 89(4):345-51. PubMed ID: 26580789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards elimination of measles and rubella in Italy: Progress and challenges.
    Adamo G; Baccolini V; Massimi A; Barbato D; Cocchiara R; Di Paolo C; Mele A; Cianfanelli S; Angelozzi A; Castellani F; Salerno C; Isonne C; Bella A; Filia A; Del Manso M; Baggieri M; Nicoletti L; Magurano F; Iannazzo S; Marzuillo C; Villari P
    PLoS One; 2019; 14(12):e0226513. PubMed ID: 31841530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience.
    Papania MJ; Wallace GS; Rota PA; Icenogle JP; Fiebelkorn AP; Armstrong GL; Reef SE; Redd SB; Abernathy ES; Barskey AE; Hao L; McLean HQ; Rota JS; Bellini WJ; Seward JF
    JAMA Pediatr; 2014 Feb; 168(2):148-55. PubMed ID: 24311021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles elimination: progress, challenges and implications for rubella control.
    Cutts FT; Lessler J; Metcalf CJ
    Expert Rev Vaccines; 2013 Aug; 12(8):917-32. PubMed ID: 23984961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles, mumps, rubella prevention: how can we do better?
    Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G
    Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles and rubella eradication in the Americas.
    Andrus JK; de Quadros CA; Solórzano CC; Periago MR; Henderson DA
    Vaccine; 2011 Dec; 29 Suppl 4():D91-6. PubMed ID: 22185837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles and rubella elimination: learning from polio eradication and moving forward with a diagonal approach.
    Goodson JL; Alexander JP; Linkins RW; Orenstein WA
    Expert Rev Vaccines; 2017 Dec; 16(12):1203-1216. PubMed ID: 29037086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verifying the Elimination of Measles and Rubella in the WHO European region: the Case of Spain.
    Santos Preciado JI
    Rev Esp Salud Publica; 2015; 89(4):353-5. PubMed ID: 26580790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles and rubella elimination in the WHO Region for Europe: progress and challenges.
    O'Connor P; Jankovic D; Muscat M; Ben-Mamou M; Reef S; Papania M; Singh S; Kaloumenos T; Butler R; Datta S
    Clin Microbiol Infect; 2017 Aug; 23(8):504-510. PubMed ID: 28111293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transitioning Lessons Learned and Assets of the Global Polio Eradication Initiative to Global and Regional Measles and Rubella Elimination.
    Kretsinger K; Strebel P; Kezaala R; Goodson JL
    J Infect Dis; 2017 Jul; 216(suppl_1):S308-S315. PubMed ID: 28838195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress Toward Rubella Elimination - World Health Organization European Region, 2005-2019.
    O'Connor P; Jankovic D; Zimmerman L; Ben Mamou M; Reef S
    MMWR Morb Mortal Wkly Rep; 2021 Jun; 70(23):833-839. PubMed ID: 34111057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global Measles and Rubella Laboratory Network, January 2004-June 2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Nov; 54(43):1100-4. PubMed ID: 16267497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slow Progress In Finalizing Measles And Rubella Elimination In The European Region.
    Biellik R; Davidkin I; Esposito S; Lobanov A; Kojouharova M; Pfaff G; Santos JI; Simpson J; Mamou MB; Butler R; Deshevoi S; Huseynov S; Jankovic D; Shefer A
    Health Aff (Millwood); 2016 Feb; 35(2):322-6. PubMed ID: 26858387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transport networks and inequities in vaccination: remoteness shapes measles vaccine coverage and prospects for elimination across Africa.
    Metcalf CJ; Tatem A; Bjornstad ON; Lessler J; O'Reilly K; Takahashi S; Cutts F; Grenfell BT
    Epidemiol Infect; 2015 May; 143(7):1457-66. PubMed ID: 25119237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.